Ocrevus, Genentech,

Monday, July 3rd, 2017

Ocrevus was approved by the FDA in March 2017 for use in Primary progressive and Relapsing forms of MS. THIS IS THE FIRST FDA APPROVED MEDICATION FOR PRIMARY PROGRESSIVE MS.

Category : Uncategorized

You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.